Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors

Extended follow-up of Hodgkin lymphoma (HL) survivors indicates that these patients are at high risk of secondary malignant neoplasms (SMNs) contributing to increased morbidity and mortality. This study examined the characteristics of HL survivors who developed SMNs with the aim to report any correl...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Abou-Antoun, Tamara (author)
مؤلفون آخرون: Mikheal, Rachelle (author), Massoud, Marcel (author), Chahine, Georges (author), Saade, Aline (author)
التنسيق: article
منشور في: 2016
الوصول للمادة أونلاين:http://hdl.handle.net/10725/4426
http://dx.doi.org/110.7314/APJCP.2016.17.2.74
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=POCPA9_2016_v17n2_749
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513463579049984
author Abou-Antoun, Tamara
author2 Mikheal, Rachelle
Massoud, Marcel
Chahine, Georges
Saade, Aline
author2_role author
author
author
author
author_facet Abou-Antoun, Tamara
Mikheal, Rachelle
Massoud, Marcel
Chahine, Georges
Saade, Aline
author_role author
dc.creator.none.fl_str_mv Abou-Antoun, Tamara
Mikheal, Rachelle
Massoud, Marcel
Chahine, Georges
Saade, Aline
dc.date.none.fl_str_mv 2016-09-27T11:36:28Z
2016-09-27T11:36:28Z
2016-09-27
dc.identifier.none.fl_str_mv 1513-7368
http://hdl.handle.net/10725/4426
http://dx.doi.org/110.7314/APJCP.2016.17.2.74
Abou-Antoun, T., Mikhael1&, R., Massoud2&, M., Chahine, G., & Saad, A. (2016). Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors. Asian Pacific Journal of Cancer Prevention, 17(2), 749-754.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=POCPA9_2016_v17n2_749
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Asian Pacific Journal of Cancer Prevention
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Extended follow-up of Hodgkin lymphoma (HL) survivors indicates that these patients are at high risk of secondary malignant neoplasms (SMNs) contributing to increased morbidity and mortality. This study examined the characteristics of HL survivors who developed SMNs with the aim to report any correlation with radiotherapy (RT) dose. In this retrospective multi-center cohort study of HL patients treated between 1990 and 2011 at three major teaching hospitals in Lebanon, classification was into two groups including those treated with combined modality (RT and chemotherapy-CHT) and those treated with CHT alone. Approval from the University Institutional Review Board (IRB) was obtained. Of the 112 patients evaluated, 52.7% (59) received the combined modality while 47.3% (53) received CHT alone. There were 6 cases of SMNs in the combined modality cohort and 5 cases in the CHT cohort. The mean RT dose in the combined modality cohort was 34.5 Gray (Gy) (SD ± 5.3). A statistically significant increase (1.5 fold) in the risk of developing SMNs was observed among patients who received a dose higher than 41 Gy compared to a dose between 20 to 30 Gy (OR= 1.5; 95% confidence interval= 0.674 to 3.339, p=0.012). The risk of SMNs was not significantly higher among patients who received extended field compared to involved field RT (p=0.964). This study showed that the risk of developing SMNs is higher among patients treated with RT dose greater than 31 Gy, independent of the RT type used.
eu_rights_str_mv openAccess
format article
id LAURepo_c973d5cdd84cfdd2c48f4ac9ce06433f
identifier_str_mv 1513-7368
Abou-Antoun, T., Mikhael1&, R., Massoud2&, M., Chahine, G., & Saad, A. (2016). Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors. Asian Pacific Journal of Cancer Prevention, 17(2), 749-754.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/4426
publishDate 2016
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma SurvivorsAbou-Antoun, TamaraMikheal, RachelleMassoud, MarcelChahine, GeorgesSaade, AlineExtended follow-up of Hodgkin lymphoma (HL) survivors indicates that these patients are at high risk of secondary malignant neoplasms (SMNs) contributing to increased morbidity and mortality. This study examined the characteristics of HL survivors who developed SMNs with the aim to report any correlation with radiotherapy (RT) dose. In this retrospective multi-center cohort study of HL patients treated between 1990 and 2011 at three major teaching hospitals in Lebanon, classification was into two groups including those treated with combined modality (RT and chemotherapy-CHT) and those treated with CHT alone. Approval from the University Institutional Review Board (IRB) was obtained. Of the 112 patients evaluated, 52.7% (59) received the combined modality while 47.3% (53) received CHT alone. There were 6 cases of SMNs in the combined modality cohort and 5 cases in the CHT cohort. The mean RT dose in the combined modality cohort was 34.5 Gray (Gy) (SD ± 5.3). A statistically significant increase (1.5 fold) in the risk of developing SMNs was observed among patients who received a dose higher than 41 Gy compared to a dose between 20 to 30 Gy (OR= 1.5; 95% confidence interval= 0.674 to 3.339, p=0.012). The risk of SMNs was not significantly higher among patients who received extended field compared to involved field RT (p=0.964). This study showed that the risk of developing SMNs is higher among patients treated with RT dose greater than 31 Gy, independent of the RT type used.PublishedN/A2016-09-27T11:36:28Z2016-09-27T11:36:28Z2016-09-27Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1513-7368http://hdl.handle.net/10725/4426http://dx.doi.org/110.7314/APJCP.2016.17.2.74Abou-Antoun, T., Mikhael1&, R., Massoud2&, M., Chahine, G., & Saad, A. (2016). Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors. Asian Pacific Journal of Cancer Prevention, 17(2), 749-754.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=POCPA9_2016_v17n2_749enAsian Pacific Journal of Cancer Preventioninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/44262021-03-19T10:00:46Z
spellingShingle Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
Abou-Antoun, Tamara
status_str publishedVersion
title Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
title_full Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
title_fullStr Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
title_full_unstemmed Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
title_short Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
title_sort Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin’s Lymphoma Survivors
url http://hdl.handle.net/10725/4426
http://dx.doi.org/110.7314/APJCP.2016.17.2.74
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=POCPA9_2016_v17n2_749